A new non-prescription weight loss product designed to absorb dietary fat before the body can digest it has arrived on shelves in major UK pharmacies. Priced at £39.90, the product offers a lower-cost alternative to existing weight loss treatments while requiring no doctor consultation or prescription to purchase. Marketed under the name formoline L112 EXTRA, the treatment aims to help individuals reduce their calorie intake and support their weight management goals through a mechanical approach rather than a systemic pharmacological one.
The rollout comes as demand for weight loss aids continues to rise across the country. While popular prescription injections such as Wegovy and Mounjaro operate by mimicking gut hormones to signal fullness and slow digestion, this tablet functions directly inside the digestive tract by binding to fats found in food. Distributed by Sterimax Global, the product became available through Pharmacy2U, LloydsPharmacy, and Well in October, with broader distribution expected through online retailers like Amazon.
How Formoline L112 Extra Works in the Body
The mechanism behind formoline L112 EXTRA differs fundamentally from prescription weight loss medications. Phil Day, superintendent pharmacist at Pharmacy2U, explains that the product functions as a medical device rather than a traditional drug because its action is entirely physical. The active ingredient is polyglucosamine L112, a dietary fibre derived from crustacean shells that binds to a portion of ingested fat within the gut. Because this fibre is not absorbed into the bloodstream and does not interact with human hormones, it provides a distinct option for individuals seeking physical management rather than chemical intervention.
Clinical investigations into the product indicate measurable outcomes for users. A three-month trial published in the journal Nutrients in 2023 evaluated 150 overweight and obese adults with a body mass index ranging from 25 to 32. Participants who took formoline L112 EXTRA alongside calorie restriction and increased physical activity lost three times more weight than those taking a control substance, while also demonstrating improvements in blood sugar and cholesterol metrics. An earlier one-year study involving an older formulation showed that users lost 63 per cent more weight compared to individuals who relied solely on dietary changes and exercise, achieving reductions in body mass index of up to 4 units.
Pricing Comparison With GLP-1 Weight Loss Injections
Cost remains a significant factor for individuals exploring weight management options. Prescription GLP-1 treatments often present a substantial financial commitment for patients paying out of pocket or navigating limited availability. A starting dose of Wegovy typically costs around £89, making formoline L112 EXTRA roughly twice as cheap at its price point of £39.90. Meanwhile, the lowest dose of Mounjaro generally costs about £149, placing the new over-the-counter tablets at approximately three times cheaper than those specific injections.
These pricing structures make the product accessible to a wider demographic of consumers. According to Sterimax Global, formoline is positioned for individuals who either do not qualify for prescription GLP-1 medications or prefer to avoid them due to concerns regarding needles or physiological side effects. Dr Leyla Hannbeck, chief executive officer of the Independent Pharmacies Association, notes that having a variety of available products is beneficial, though she emphasises the importance of professional guidance. She recommends that patients consult with a pharmacist before starting any new regimen to ensure suitability.
Dosage Guidelines and Treatment Duration
Proper usage is essential for achieving the intended effects of the product. The manufacturer advises taking formoline L112 EXTRA twice a day alongside your two main meals, swallowing two tablets at each instance with a minimum of 250 millilitres of fluid. A standard package containing 64 tablets will last for 16 days under this recommended dosage schedule. For individuals focusing on weight maintenance rather than active weight reduction, the intake can be reduced to two tablets daily taken with the two main meals.
Results depend heavily on sustained lifestyle habits. Because the product targets only the fat present in consumed meals, users must still maintain a calorie-controlled diet and engage in regular physical activity to see a reduction in weight. Manufacturer guidelines state that individuals should use the tablets consistently for at least three months to evaluate their effectiveness. For lighter maintenance phases or long-term weight control, the lower daily dosage can be used continuously while maintaining healthy dietary habits.
Potential Side Effects and Safety Considerations
Like many health products affecting the digestive tract, formoline can cause gastrointestinal side effects. Common reactions include bloating, flatulence, and constipation as the body adjusts to the increased dietary fibre and bound fats. Phil Day advises users to consume plenty of fluids, aiming for around two litres a day to mitigate these digestive issues. The consistency of bowel movements may also alter during the course of the treatment. Rare allergic reactions can occur, presenting as skin rashes, itching, redness, nausea, vomiting, stomach cramps, or diarrhoea.
Particular caution is advised for individuals with specific allergies or sensitivities. The manufacturer highlights that some adverse reactions have been observed in people with dust mite allergies, as the active ingredient is sourced from crustacean shells. Anyone experiencing side effects should discontinue use immediately and seek advice from a pharmacist or medical doctor. Additionally, individuals taking regular medications must time their doses carefully, as the fat-binding properties can interfere with the absorption of critical drugs and essential nutrients.
Who Should Avoid Taking the New Fat-Absorbing Pill?
The product is intended specifically for adults carrying excess weight, with the EXTRA strength formulation targeted at individuals weighing more than 75 kilograms who possess a body mass index of 25 or higher. It is strictly unsuitable for individuals who are underweight, defined as having a body mass index of 18.5 or below. Furthermore, because the binding mechanism can reduce the body absorption of fat-soluble vitamins including vitamins A, D, E, and K, as well as essential medications such as the contraceptive pill, blood thinners, and certain epilepsy treatments, timing is critical. Other medications and supplements must be taken at least four hours apart from the tablets.
Certain populations must avoid the product entirely or seek professional medical clearance before starting. A comprehensive set of restrictions governs who should refrain from using the tablets:
- You are allergic to crustaceans or to any of the listed ingredients, as polyglucosamine L112 is derived from crustacean shells
- You are underweight, or have a body mass index under 18.5
- You are pregnant or breastfeeding
- You have chronic constipation or a blocked bowel
- You are taking long-term medicines that slow the bowel
- You are under the age of 18
Phil Day stresses that individuals must speak to their pharmacist or general practitioner first if they take regular medication, suffer from severe digestive conditions such as ulcerative colitis or Crohn disease, or have previously undergone gut surgery. The same precautionary advice applies to any individual over the age of 80, ensuring that underlying health conditions are appropriately managed before introducing a new physical supplement.